Featuring: Ali Baig, PharmD Candidate c/o 2023By: Helen Li, PharmD Candidate c/o 2023 Ali Baig is a sixth-year pharmacy student at St. John’s University. During his time at St. John’s, Ali cultivated skillsets in business management, starting with his own car detailing business and eventually opening his own franchise of Edible Arrangements. Ali’s interests in…

By: Geraldine Ciaccio, PharmD Candidate c/o 2025               Young children with type 1 diabetes (T1D) are completely dependent on others for their care and management. It can be hard for parents, guardians, teachers, and healthcare providers to assess a child’s condition as they are too young to properly communicate their thoughts and emotions. Most children…

By: Imaan Sekhery, PharmD Candidate c/o 2025 ​              On July 6, 2022, the Food and Drug Administration (FDA) revised the precedent Emergency Use Authorization (EUA) for Pfizer’s Paxlovid, granting licensed pharmacists the right to prescribe Paxlovid to suitable patients. This revision will significantly increase access to Paxlovid, assisting in patient recovery from Coronavirus Disease 2019…

By: Zarin Chowdhury, PharmD Candidate c/o 2023 and Lauren Merkovich, PharmD Candidate c/o 2023               Type 2 diabetes (T2D) is a long-term medical condition in which the body is unable to use insulin properly, resulting in abnormal blood glucose levels.1 More than 37 million Americans have diabetes (about 1 in 10); approximately 90 to 95%…

By: Kelly Lavery, PharmD Candidate c/o 2024               Increasing rates of childhood obesity remain a major risk factor behind a recently increased prevalence of diabetes in the pediatric population. This subject is of particular relevance in light of the ongoing coronavirus disease of 2019 (COVID-19) pandemic, which has limited children to isolation and online learning…

By: Sairah Sheikh, PharmD Candidate c/o 2024                  Promising new research conducted by doctors at Memorial Sloan Kettering Cancer Center showed 100% remission of rectal cancer in 12 patients after immunotherapy. Traditionally, patients with rectal cancer are treated with chemotherapy and radiation, followed by a surgical resection of the rectum.1 However, this method carries the…

Featuring: Colleen Bond, PharmD, BCPSBy: Justin Budz, PharmD Candidate c/o 2023 At a young age, Dr. Colleen Bond was involved in the care of a close relative, gaining early exposure to the healthcare team dynamic. The one question that no one was able to clearly answer was how medications were able to work in the…